BROMOCRIPTINE MESYLATE (BROMOCRIPTINE MESYLATE)
Pending LLM rewrite. Source: FDA_DRUG D-0159-2026.
Severity not yet assessed
We have not scored this recall against our rubric yet, so we are not showing a severity rating or our usual guidance. The agency’s own notice below is the authoritative source — read it first.
Plain-English summary
Failed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate Capsules.
The recalled product
- Product
- BROMOCRIPTINE MESYLATE (BROMOCRIPTINE MESYLATE)
- Brand
- BROMOCRIPTINE MESYLATE
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (15)
- Lot #: M313934
- M313935
- M315615
- Exp. Date Nov 2025
- M316809
- Exp. Date Dec-25
- M405765
- M405763
- M405764
- Exp. Date Apr-26
- M414999
- M414241
- M414307
- M414305
- Exp. Date Oct-26
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22